APinnov 2025

10 juin 2025 | France

Institut de la leucémie

Société Privée

Paris, France
1 visite de profil

Détails

THEMA Saint-Louis is a central hub for the landscape of research, therapeutic innovation and education in leukemia. Its aim is to develop a curative precision medicine for leukemia patients in combination with chemo and cell therapies. Gathering research and clinical teams from Saint Louis, Avicenne, Necker, Cochin, Robert Debré, Collège de France, Francois Jacob Institute, CEA, ESPCI, and Polytechnique, THEMA Saint-Louis hosts one of Europe's largest groups of leukemia patients.

MOTS CLES

Cytologie, Cancérologie, oncologieDiagnostic

Représentants

Charlotte Bouquerel

Responsable du développement, Institut de la Leucémie

Institut de la leucémie